{"disease":{"id":"myotonic-disorder","name":"Myotonic disorder","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"mexiletine","indication_name":"Myotonic disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mexitil","generic_name":"MEXILETINE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Antiarrhythmic","quality_score":66,"revenue":null,"mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05027269","title":"Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Avidity Biosciences, Inc.","has_results":false},{"nct_id":"NCT05479981","title":"Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Avidity Biosciences, Inc.","has_results":false},{"nct_id":"NCT04622553","title":"Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":14,"lead_sponsor_name":"Lupin Ltd.","has_results":false},{"nct_id":"NCT07154654","title":"Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Lupin Ltd.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}